News

• J&J's Q4 sales down 4.4% to $24B on lower COVID-19 vaccine sales
  01/24/2023 / 12:27 - TeleTrader
•  
• J&J reportedly cuts COVID vaccine production
  01/13/2023 / 17:14 - TeleTrader
•  
• Abiomed skyrockets 50% on J&J's takeover deal
  11/01/2022 / 17:46 - TeleTrader
•  
• J&J to reduce headcount despite robust sales
  10/18/2022 / 18:29 - TeleTrader
•  
• J&J's Q3 sales up 1.9% to $23.8 billion
  10/18/2022 / 12:27 - TeleTrader
•  
• J&J launches $5B share buyback program
  09/14/2022 / 12:48 - TeleTrader
•  
• J&J to stop selling talc-based baby powder in 2023
  08/12/2022 / 00:54 - TeleTrader
•  
• J&J posts Q2 EPS of $1.8, dropping 23.4% YoY
  07/19/2022 / 12:26 - TeleTrader
•  
• FDA limits J&J vaccine use due to blood clot risks
  05/06/2022 / 02:58 - TeleTrader
•  
• J&J's Q1 sales up 5% YoY to $23.4B
  04/19/2022 / 12:27 - TeleTrader
•  
• CDC confirms additional boosters for over-50s
  03/29/2022 / 22:41 - TeleTrader
•  
• Johnson: Putin must know he would pay high price for invasion
  02/19/2022 / 11:37 - TeleTrader
•  
• Top NoSQL Innovators Honored with ScyllaDB Awards
  02/16/2022 / 14:58 - GlobeNewswire
•  
• Report: J&J quietly paused COVID vaccine production
  02/08/2022 / 17:01 - TeleTrader
•  
• J&J Q4 EPS soars 172.3% to $1.77
  01/25/2022 / 12:31 - TeleTrader